Barclays Maintains Equal-Weight on CME Group, Lowers Price Target to $316

Benzinga Newsdesk www.benzinga.com Negative 65.7%

Neg 65.7% Neu 0% Pos 0%

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and lowers the price target from $343 to $316.